RT Journal Article SR Electronic T1 A deep transcriptome meta-analysis reveals sex-based molecular differences in Multiple Sclerosis JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.08.31.21262175 DO 10.1101/2021.08.31.21262175 A1 José Francisco Català-Senent A1 Zoraida Andreu A1 Francisco José Roig A1 Marta R. Hidalgo A1 Natalia Yanguas-Casás A1 Almudena Neva-Alejo A1 Adolfo López-Cerdán A1 Irene Soler-Sáez A1 María de la Iglesia-Vayá A1 Francisco García-García YR 2021 UL http://medrxiv.org/content/early/2021/09/02/2021.08.31.21262175.abstract AB Background Multiple Sclerosis (MS) is a chronic autoimmune, inflammatory, and degenerative disease of the central nervous system that affects both women and men but the risk of developing MS is higher in women (2-3:1 ratio compared to men). Current knowledge does not allow a precise definition of the sex-related factors intervening in MS. Here, we explore the role of sex in this neurodenegerative disease to identify molecular mechanisms underlying sex-based diferences that can guide novel therapeutics approaches aimed for men and women.Methods We performed a rigorous and systematic review of MS whole transcriptome studies that included sex patient information in Gene Expression Omnibus and ArrayExpress databases, following PRISMA statment guidelines. A differential gene expression (DGE) was performed for each selected study. Then, three meta-analyses based on genes and different contrasts were addressed to evaluate common features and sex bias in all scenarios: one meta-analysis in nervous tissue studies (4), another in blood studies (5), and a third that integrated the studies from both tissues, blood and nervous system (9). Finally, a gene set analysis (GSA) was performed on the meta-analyzed differential transcriptomic profile between women and men, to study their involvement in biological pathways and phenotypes (physiological and pathological states) sex related.Results After screening 122 publications, the systematic review provided a selection of nine studies (5 in blood and 4 in nervous tissue) with a total of 653 samples (269 MS women, 152 control women, 116 MS men, 116 control men). The blood sex-differences gene meta-analysis identified 1 gene overexpressed in women (KIR2DL3) while gene meta-analysis in the nervous tissue resulted in 5 genes differentially expressed (4 overexpressed in women: C7orf73, CECR7, TRAF3IP2-AS1, ZNF117; and 1 overexpressed in men: HIST1H2AE). In the global meta-analysis (blood and nervous tissue), 1 gene involved in sex differences were detected (more expressed in women: LOC102723701). 9 MS biomarkers were also identified in both sexes (4 overexpressed genes in MS patients: HIST1H2BC, SMEK2, STBD1, TMEM140) and 5 down-regulated in MS patients: C16orf59, C20orf177, C9orf23, FAM65B, PKI55). Additionally, the GSA related to gene meta-analysis revealed a set of functions differentially enriched in men and women, in the different analysed tissues.Conclusion These findings provide valuable opportunities for better understanding of MS related sex differences and develop effective and sex-specific interventions down further studies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch supported by Principe Felipe Research Center and GV/2020/186 grant.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This work does not need any approval of the IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe large volume of data and results generated in this study are freely available through the Metafun-MS web tool: http://bioinfo.cipf.es/metafun-MS and the zenodo repository: http://doi.org/10.5281/zenodo.5211962. This study analyzed transcriptomic data available in the Gene Expression Omnibus database with accession numbers GSE37750, GSE41848, GSE41849, GSE41890, GSE62584, GSE108000, GSE111972, GSE131281, and GSE135511. http://doi.org/10.5281/zenodo.5211962 BHBenjamini & Hochberg p-value adjust methodBPBiological processes of Gene OntologyCISClinical Isolated SyndromeDGEDifferential gene expressionGEOGenes Omnibus Expression databaseGOGene OntologyGSAGene set analysisKEGGKyoto Encyclopedia of Genes and GenomesLogFCLogarithm of the fold changeLORLogarithm of odds ratioMSMultiple SclerosisPCAPrincipal component analysisPRMSProgressive-Relapse Multiple SclerosisRRMSRelapsing-Remitting Multiple SclerosisSPMSSecondary-Progressive Multiple Sclerosis.